Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript

Vaxart, Inc. (VXRT) Q4 2025 Earnings Call Transcript

Full year 2025 business update and financial results conference call to be held March 12 at 4:30 p.m. ET Stockholder fireside chat to be held on March 13 at 4:30 p.m.

At a time when many investors are rotating out of speculative penny stocks, others continue to embrace the risk-reward dynamic. Stocks that trade for under $5 carry a certain amount of risk.

NEW YORK--(BUSINESS WIRE)--Hagens Berman Sobol Shapiro LLP & Scott+Scott Attorneys at Law LLP: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA In re VAXART, INC. SECURITIES LITIGATION This Document Relates to: ALL ACTIONS Master Case No. 3:20-cv-05949-VC SUPPLEMENTAL SUMMARY NOTICE OF CLASS CERTIFICATION THIS SUPPLEMENTAL NOTICE PROVIDES ONLY LIMITED INFORMATION ABOUT THE CASE PLEASE VISIT WWW.VAXARTSECURITIESLITIGATION.COM FOR MORE INFORMATION The Court has certified this laws.

Penny stocks attract speculative investors looking for high-risk/high-reward opportunities. That means looking for companies with disruptive technologies, that are part of an emerging trend, or ones that have a compelling turnaround story.

SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart or “the Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it will participate in the Global BioInnovation Forum, a virtual gathering of senior leaders building and scaling next-generation life science and health innovation companies.